05/01/2024
3:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:21 PM | Aptose Biosciences (Filer)
| Form PRE 14A | |
04/29/2024
4:19 PM | Aptose Biosciences (Filer)
| Form 10-K/A | |
04/26/2024
11:54 AM | Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
| Form SC 13D/A | |
04/26/2024
6:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:05 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2024
4:00 PM | Aptose Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/26/2024
3:04 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
4:45 PM | Aptose Biosciences (Issuer)
Bejar Rafael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
5:06 PM | Aptose Biosciences (Issuer)
Payne Fletcher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
4:26 PM | Aptose Biosciences (Issuer)
LEDRU PHILIPPE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
8:44 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/26/2024
4:30 PM | Aptose Biosciences (Filer)
| Form 424B4 | |
01/26/2024
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
11:15 PM | Aptose Biosciences (Filer)
| Form EFFECT | |
01/25/2024
8:44 PM | Aptose Biosciences (Filer)
| Form S-1MEF | |
01/19/2024
8:50 PM | Aptose Biosciences (Filer)
| Form S-1/A | |
12/29/2023
3:10 PM | Aptose Biosciences (Filer)
| Form S-1/A | |
12/11/2023
5:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
5:15 AM | Aptose Biosciences (Filer)
| Form S-1/A | |
12/01/2023
7:29 PM | Aptose Biosciences (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/30/2023
4:28 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:00 PM | Aptose Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
8:15 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
8:20 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2023
9:12 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2023
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
4:03 PM | Aptose Biosciences (Issuer)
Seizinger Bernd R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/21/2023
4:10 PM | Aptose Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/18/2023
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
5:23 PM | Aptose Biosciences (Subject)
Hanmi Pharmaceutical Co., Ltd. (Filed by)
| Form SC 13D | |
09/06/2023
7:01 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
7:00 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2023
11:15 PM | Aptose Biosciences (Filer)
| Form EFFECT | |
06/28/2023
3:15 PM | Aptose Biosciences (Filer)
| Form S-1/A | |
06/26/2023
3:10 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
5:05 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
6:40 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2023
6:30 AM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
4:30 PM | Aptose Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
05/08/2023
4:26 PM | Aptose Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
